Here are relevant reports on : photodynamic-therapy-market
-
Fill Finish Manufacturing Market by Consumables (PFS [System, Plunger Stoppers, Glass, Polymer], Vials [Bulk, RTU], Vial Stoppers, Cartridges, Cell Therapy Bags), Instruments (Integrated), Type (Automated), Services, Competition - Global Forecast to 2031
The global fill finish manufacturing market is projected to reach USD 30.37 billion by 2031, growing at a CAGR of 9.0% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Digital Biomarkers Market by Type (Physiological, Vocal, Idiosyncratic), Therapy [Cardio, Onco (Lung, Breast Cancer), Mental Health, Neuro], Application [Clinical Research (Phase IV)], End User (Pharma & Biotech Companies, CROs) – Global Forecast to 2031
The global digital biomarkers market is projected to reach USD 17.73 billion by 2031, growing at a CAGR of 19.1% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Medical Devices and Supplies Market by Product (Anesthesia, Patient Monitoring, Infusion Pumps, Consumables), Application (Diagnosis, Monitoring, Therapy, Surgical), Animal Type (Companion Animals, Large Animals) - Global Forecast to 2030
The global veterinary medical devices and supplies market, valued at US$2.50 billion in 2024, stood at US$2.66 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2024 to 2030, culminating in a forecasted valuation of US$3.60 billion by the end of the period. The market growth is driven by the rising pet ownership and increasing expenditure on animal healthcare, coupled with the growing prevalence of chronic and infectious diseases in companion and livestock animals.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Hyperbaric Oxygen Therapy Equipment Market by Product (Hyperbaric Oxygen Chambers, Chamber Accessories, Consumables), Application (Injuries, Infections, Insufficiencies), End User - Global Forecast to 2022
The global hyperbaric oxygen therapy equipment market is expected to reach $3.21 Billion by 2022 from $2.26 Billion in 2017, growing at a CAGR of 7.1% from 2017 to 2022. Rising incidence and prevalence of acute and chronic wounds, ready availability of hyperbaric oxygen therapy systems, and growing popularity of leisure and adventure activities are some of the major driving factors driving the growth of the global hyperbaric oxygen therapy equipment market. However, the high cost of treatment and challenges in reimbursement are hindering the growth of this market to a certain extent.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
CAR-t Cells Therapy Market by Type, End-Use Industry, Application and Region – Global Forecast to 2030
CAR-t Cells Therapy Market
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Transdermal Pharmaceutical Packaging Market by Type (Patches, Gels), Material (Plastic, Glass, Metal), Application (Chronic Disease Management, Pain Management, Hormone Replacement Therapy), and Region – Global Forecast to 2030
The transdermal pharmaceutical packaging market is projected to grow from USD 4.05 billion in 2025 to USD 8.13 billion by 2030, at a CAGR of 15.0%. The key players in the transdermal pharma packaging market include 3M Company (US), Hisamitsu Pharmaceutical (Japan), Novartis (Switzerland), Teva Pharmaceutical Industries (Israel), Johnson & Johnson (US), Bayer (Germany), GlaxoSmithKline (UK), LTS Lohmann Therapie-Systeme (Germany), Noven Pharmaceuticals (US), and Nitto Denko (Japan).
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Leukapheresis Market by Type (Filter, Membrane Separator, Centrifugal Device), Leukopak (Mobilized, Isolated PBMC), Application (Research [Cell & Gene Therapy, Transplantation], Therapeutic), Indication, End User, Region - Global Forecast to 2031
The global Leukapheresis market, valued at USD 83.3 billion in 2025, stood at USD 90.6 billion in 2026 and is projected to advance at a resilient CAGR of 8.9% from 2026 to 2031, culminating in a forecasted valuation of USD 138.7 billion by the end of the period. This growth is driven by the increasing number of therapeutic and manufacturing applications for leukapheresis in hematologic disorders, as well as the rising demand for high-quality starting materials used in cell and gene therapy, including CAR-T, TCR, and NK-cell programs.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Decentralized Cell Therapy Manufacturing Market By Product & Service (Automated Closed-System Platforms, Consumables, Services), Workflow (Autologous [CAR-T, TCR-T]), End User (Hospitals, Pharma & Biotech Companies) – Global Forecast To 2031
Decentralized Cell Therapy Manufacturing Market
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Cryovials Market by Material (Polypropylene, Polyethylene, Glass), Application (Biobanking, Clinical Diagnostics, Cell & Gene Therapy, Drug Discovery), End User (Hospitals, Academia, Pharma-biopharma Cos., Biobanks) - Global Forecast to 2031
The global cryovials market is projected to reach USD 0.31 billion by 2031, growing at a CAGR of 5.5% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Vitamin D Therapy Market by Route of administration (Oral, Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases) - Global Forecast to 2024
The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6% during the forecast period. Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population. On the other hand, the fortification of foods is likely to challenge the growth of this market. Some of the major players in this market include Abbott (US), Sanofi (France), GlaxoSmithKline plc (UK), Pfizer Inc. (US), Merck & Co., Inc. (US), Torrent Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Alkem Laboratories (India), Sun Pharmaceutical Industries Ltd. (India), and Cadila Healthcare Ltd. (India).
- Published: April 2019
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
